Iron-deficiency Anemia Clinical Trial
Official title:
Effect of Daily Bovine Lactoferrin Supplementation on Fetal Development and Iron Metabolism in Healthy Pregnant Women: A Randomized Double-blind Controlled Trial
To assess the effects of a lactoferrin supplemented formula on fetal development , iron metabolism and immunity in healthy pregnant women. One hundred and twenty healthy pregnant women (24<gestational weeks<26) are enrolled and randomly assigned to lactoferrin-supplemented formula group (active group) or normal formula group (control group, without lactoferrin supplementation). Subjects allocated in active group consume lactoferrin supplemented formula (85mg lactoferrin per 100g) 3 times a day (81g totally), while those in control group consume formula without lactoferrin supplementation (<6mg lactoferrin per 100g formula) according to the same schedule. Routine blood test including hemoglobin and serum ferritin, and food frequency questionnaire-based review and 24h*3 dietary record are performed every 4 weeks during intervention until delivery. Body weight of newborns are recorded after delivery. The differences in iron deficiency anemia morbility of pregnant women and anthropometric measurements of newborns between groups would be analyzed after completion of this study.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04949165 -
Bloodsafe Ghana- Iron and Nutritional Counseling Strategy Pilot Study
|
N/A | |
| Active, not recruiting |
NCT02541708 -
IV Ferric Carboxymaltose Compared With Oral Iron in the Treatment of Iron Deficiency Anemia at Delivery in Tanzania
|
Phase 3 | |
| Completed |
NCT01942460 -
Ferumoxytol for Iron-Deficiency Anemia in Chronic Kidney Disease and Peritoneal Dialysis Patients
|
Phase 4 | |
| Completed |
NCT01047098 -
Effects of Taking Prenatal Vitamin-mineral Supplements During Lactation on Iron Status and Markers of Oxidation
|
N/A | |
| Completed |
NCT00810030 -
FERINJECT for Correction of Anaemia in IBD Patients, FER-IBD-COR
|
Phase 3 | |
| Completed |
NCT00298051 -
Umbilical Cord Clamping and Infant Iron Status
|
N/A | |
| Completed |
NCT01135576 -
Iron Fortified Beverages and Application in Women Predisposed to Anemia
|
N/A | |
| Withdrawn |
NCT04320966 -
Neurovascular Complications and White Matter Damage in Acquired Anemias
|
||
| Completed |
NCT01101399 -
Ferric Carboxymaltose in Subjects With Functional Iron Deficiency Undergoing Chemotherapy
|
Phase 3 | |
| Completed |
NCT05240677 -
Endoscopy in CKD With Iron Deficiency Anemia
|
N/A | |
| Terminated |
NCT01100879 -
Ferric Carboxymaltose for Treatment of Anaemia of Cancer in Subjects With Multiple Myeloma Receiving Chemotherapy
|
Phase 4 | |
| Recruiting |
NCT02487719 -
Different Iron Supplements for Prevention of Anemia in Pregnancy
|
Phase 4 | |
| Recruiting |
NCT03232554 -
Buxue Yimu Pills for Gynecological Iron-Deficiency Anemia
|
Phase 2 | |
| Terminated |
NCT02341300 -
Use of Cast Iron Pots to Improve Maternal Anemia
|
N/A | |
| Completed |
NCT04318405 -
Real Life Study on Iron Isomaltoside 1000 in the Treatment of ID in CKD, Heart Failure, ObGyn, IBD, Cancer and Elective Surgery (Real-CHOICE).
|
||
| Completed |
NCT02998697 -
Short Term Oral Iron Supplementation in Systolic Heart Failure Patients Suffering From Iron Deficiency Anemia
|
Phase 2/Phase 3 | |
| Not yet recruiting |
NCT03411590 -
The Effect of Fortified Growing-up Milk on Growth and Micronutrient Status of Nigerian Toddlers
|
N/A | |
| Completed |
NCT05365308 -
EHR-based Patient Identification and Panel Management of Patients With Iron Deficiency Anemia
|
N/A | |
| Recruiting |
NCT01071759 -
Effects of Dietary Heme/Non-heme Iron and Helicobacter Pylori (Hp) Infection on Maternal Iron-deficiency Anemia and Fetal Growth Outcomes
|
N/A | |
| Terminated |
NCT00882414 -
Ferinject® in Patient With Thrombocytosis Secondary to Inflammatory Bowel Disease (IBD)
|
Phase 2 |